Pages that link to "Q53158682"

The following pages link to Prognostic significance of interim 18F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma (Q53158682):

Displaying 39 items.

• PET Scans for Staging and Restaging in Diffuse Large B-Cell and Follicular Lymphomas (Q26752284) (← links)
• Predictive Efficacy of Interim Positron Emission Tomography/Computed Tomography (PET/CT) for the Treatment of Aggressive Lymphoma (Q26771059) (← links)
• The use of FDG-PET in diffuse large B cell lymphoma (DLBCL): predicting outcome following first line therapy (Q26863624) (← links)
• Heterogeneous bone marrow uptake on interim 18F-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report (Q34495877) (← links)
• Potential role of (18)F-2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography imaging in patients presenting with generalized lymphadenopathy. (Q34908079) (← links)
• Use of subsequent PET/CT in diffuse large B-cell lymphoma patients in complete remission following primary therapy (Q35178725) (← links)
• Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma (Q35439403) (← links)
• 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell Lymphoma (Q35855599) (← links)
• Prognostic value of interim (18)F-FDG-PET in diffuse large B cell lymphoma treated with rituximab-based immune-chemotherapy: a systematic review and meta-analysis (Q35858346) (← links)
• Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404) (Q36417808) (← links)
• Prognostic value of interim (18)F-FDG PET/CT in diffuse large B-cell lymphoma (Q36563201) (← links)
• Baseline total lesion glycolysis measured with (18)F-FDG PET/CT as a predictor of progression-free survival in diffuse large B-cell lymphoma: a pilot study (Q36769240) (← links)
• Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL. (Q36897012) (← links)
• Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. (Q37240835) (← links)
• Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma (Q37700942) (← links)
• Diffuse large B-cell lymphoma: is there a place for autologous hematopoietic stem cell transplant in first remission in the era of chemo-immunotherapy? (Q37997054) (← links)
• When should FDG-PET be used in the modern management of lymphoma? (Q38153086) (← links)
• Value of interim FDG PET/CT for predicting outcome of patients with angioimmunoblastic T-cell lymphoma (Q38410048) (← links)
• Utility of interim and end-of-treatment PET/CT in peripheral T-cell lymphomas: A review of 124 patients. (Q38552173) (← links)
• The Association Between Liver and Tumor [18F]FDG Uptake in Patients with Diffuse Large B Cell Lymphoma During Chemotherapy. (Q38763481) (← links)
• FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas (Q38836081) (← links)
• Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14 (Q40356629) (← links)
• Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project (Q41151021) (← links)
• The predictive value of interim and final [18F] fluorodeoxyglucose positron emission tomography after rituximab-chemotherapy in the treatment of non-Hodgkin's lymphoma: a meta-analysis (Q42033589) (← links)
• Prognostic nomogram for diffuse large B-cell lymphoma incorporating the International Prognostic Index with interim-positron emission tomography findings (Q46626902) (← links)
• Predictive value of interim PET/CT visual interpretation in the prognosis of patients with aggressive non-Hodgkin's lymphoma (Q47252205) (← links)
• Interim PET-CT may predict PFS and OS in T-ALL/LBL adult patients (Q47788594) (← links)
• Different predictive values of interim 18F-FDG PET/CT in germinal center like and non-germinal center like diffuse large B-cell lymphoma. (Q48355928) (← links)
• Interim 18F-FDG PET/CT improves the prognostic value of S-IPI, R-IPI and NCCN-IPI in patients with diffuse large B-cell lymphoma (Q48516167) (← links)
• Early interim PET/CT predicts post-treatment response in diffuse large B-cell lymphoma. (Q53061964) (← links)
• (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study. (Q53082718) (← links)
• Positive correlation between baseline PET or PET/CT findings and clinical parameters in multiple myeloma patients. (Q53086997) (← links)
• Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphoma. (Q53098940) (← links)
• Use of interim [18F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy. (Q53207684) (← links)
• Risk stratification of diffuse large B-cell lymphoma with interim PET-CT based on different cutoff Deauville scores. (Q53211003) (← links)
• Guidelines for the management of diffuse large B-cell lymphoma. (Q54708579) (← links)
• Prognostic analysis of interim F-FDG PET/CT in patients with diffuse large B cell lymphoma after one cycle versus two cycles of chemotherapy (Q58583717) (← links)
• Risk Stratification Of Diffuse Large B-Cell Lymphoma With Interim PET/CT By Combining Deauville Scores And International Prognostic Index (Q91738281) (← links)
• Interim PET/CT based on visual and semiquantitative analysis predicts survival in patients with diffuse large B-cell lymphoma (Q91779198) (← links)